This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
 
Cancer.gov0 0 Division of Cancer Prevention

 

DCP Home
Dictionary
Site Map
Search

PROSTATE, LUNG, COLORECTAL & OVARIAN CANCER SCREENING TRIAL (PLCO)

Updates

News Updates

Bibliography


Articles

Alexander FE, Andriole GL, Aus G, Auvinen A, Beensterboer P, Blijenberg BG, Bonardi R, Buys S, Candas B, Ciatto S, Crawford ED, Demers R, de Koning HJ, Denis L, Dijk MA, Figueiredo F, Gelmann EP, Gohagan J, Hakama M, Hugosson J, Kirkels WI, Kranse R, van der Kwast TH, Lilja H, Maattanen L, Mandel J, Miller AB, Moneiro H, Nelen V, Oberman A, Paez A, Prorok PC, Reding D, Rietbergen JWBW, Rose DB, Sanchez AB, Schroder FH, da Silva EC, Simpson N, Smith PH, Stadaert B, Stenman UH, Teppo L, Turkes A, Weissfeld JL, Yokochi L (The International Prostate Screening Trial Evaluation Group) Review: rationale for randomised trials of prostate cancer screening, The International Journal of Cancer, 1999, 35:2, 262-271.

Auvinen A, Rietbergen JBW, Denis LJ, Schroder FH, Prorok PC., Prospective evaluation plan for randomised trials of prostate cancer screening. Journal of Medical Screening, 1996, 3:97-104.

DeKoning HJ, Auvinen A, Sanchez AB, Da Silva FC, Ciatto SD, L, Gohagan JK, Hakama M, Hugosson J, Krranse R, Nelen V, Prorok PC, Schroder FH. Large-scale rndomized prostate cancer screening trials: program performance in the european randomized screening for prostate cancer trial and the Prostate, Lung, Colorectal and Ovary Cancer Screening Trial. Int. Journal of Cancer, 2002; 97, 237-244.

Ford ME, Havstad SL, Flickinger L, Johnson CC. Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence. Cancer, Epidemiology, Biomarkers and Prevention, 2003, 12:1, 28-33.

Ford ME, Havstad MA, Tilley BC. Recruiting older african american men to a cancer screening trial (The AAMEN Project). The Gerontologist, 2003, 43:1, 27-35.

Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL. Relationship of demographic and clinical factors to free and total PSA. Urology, 2001, 58(4):561-566.

Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest, 2004 Jul;126(1):114-21.

Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute. Journal of Urology, 1994, 152:5, 1905-1909.

Gohagan JK, Kramer BS, & Greenwald P. Screening for prostate cancer. American Journal of Preventive Medicine, 1994, 10:4, 245-246.

Gohagan J, Prorok P, Kramer B, Cornett J. Screening for ovarian cancer: epidemiological aspects, study design, and target population. In Epithelial Cancer of the Ovary, BMJ Publishing Group, 1995, 59-67.

Gohagan JK, Prorok PC, Kramer BS, et al. The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial of the National Cancer Institute. Cancer Supplement, 1995, 75:7, 1869-1873.

Gohagan JK. PLCO Screening Trial. AUA News, 1997, Jan/Feb, 11.

Gohagan JK, Prorok PC, Hayes R, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Controlled Clinical Trials, 2000, 21(6S):251S-272S.

Gohagan JK, Marcus PM, Fagerstrom RM et al. Screening for lung cancer. In: Williams C, ed. Evidence-based Oncology. London: BMJ Books, 2003 (p164-71).

Hartge P, Hayes R, Reding D, Sherman ME, Prorok P, Schiffman M, Buys S. Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors. Am. J Obstet Gynecol, 2000:83:5, 1232-1237.

Hasson MA, Fagerstrom R, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials, 2000, 21(6S):329S-348S.

Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, Caporaso N, Ziegler R, Johnson CC, Weissfeld J, Hoover RN, Hartge P, Palace C, Gohagan JK, Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Controlled Clinical Trials, 2000, 21(6S):349S-355S.

Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC. Whole blood cyropreservation in epidemiological studies. Cancer Epidemiology Biomarkers Prevention. 2002; 11:1496-1498.

Kramer BS, Gohagan J, Prorok PC, Smart C. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian Cancers. Cancer Supplement, 1993, 71:2, 589-593.

Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Annals of Internal Medicine. 1993, 119:9, 914-923.

Kramer BS, Gohagan J, Prorok PC. NIH consensus 1994: Screening, Gyn Oncol, 1994, 55:S20-S21.

McFarland EG. Brink JA. Helical CT colongraphy (virtual colonoscopy): the challenge that exists between advancing technology and generalizability, American Journal of Roentgenology, 1999, 173:549-559.

McFarland EG, Brink JA, Pilgram TK, Heiken JP, Balfe DM, Hirselj D, Weinstock L, Littenberg B. Spiral CT colonography: reader agreement and diagnostic performance with two and three-dimensional image-display techniques. Radiology, 2001, 218 (2): 375-383.

McFarland EG, Pilgram TK, Brink JA, McDermott RA, Santillan CV, Brady PW, Heiken JP, Balfe DM, Weinstock LB, Thyssen EP, Littenberg B. CT colonography: multiobserver diagnostic performance. Radiology, 2002; 225:380-390.

Miller AB, Yurgalevitch S, Weissfeld JL. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials, 2000, 21(6S):400S-406S.

Miller AB, Madalinska, Church T, Crawford D, Essink-Bot, JL, Goel V, de Koning HJ, Maattanen L, Pentikainen T. Health-related quality of life and cost-effectiveness studies in the european randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary Trial. European Journal of Cancer, 2001, 37:2154-2160.

O’Brien B, Nichaman L, Browne JEH, Levin, D, Prorok, PC & Gohagan, JK. Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Controlled Clinical Trials, 2000, 21(6S):310S-328S.

Peters U, Sinha R, Chatterjee N, Subar A, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB. Dietary fibre and colorectal adenoma in a colorectal cancer early detecion programme. The Lancet. May 3, 2003, 361:1491-1495.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA, PLCO Project Team. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiology Biomarkers Prevention, April 2004, 13(4).

Pinsky PF. Estimation and prediction for cancer screening models using deconvolution and smoothing. Biometrics, 2001 June;57(2):389-95.

Pinsky PF, Schoen RE, Weissfeld, JL, Bresalier RS, Hayes RB, Gohagan JK, Predictors of adanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clinical Gastroenterology and Hepatology. March 2003, 1:2

Pinsky PF, Kramer BS, Reding D, Buys S. Reported family history of cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Epidemiology, May 2003, 157(9):792-9.

Prorok PC, Byar DP, Smart CR, Baker SG, Connor RJ. Evaluation of screening for prostate, lung and colorectal cancers: The PLC Trial. In Miller AB, Chamberlain J, Dah NE, Hakama M, Prorok PC (eds). Cancer Screening, 1991, 300-320.

Prorok PC, Gohagan J, Kramer B. The National Cancer Institute multi-screening trial. Canadian Journal of Urology, 1994, 4:1, 98-101.

Prorok PC, Potosky AL, Gohagan JK, Kramer BS. Prostate cancer screening: Current issues. In: AB Miller (ed.), Advances in Cancer Screening, Boston: Kluwer Academic Publishers, 1996, 93-112.

Prorok PC, Andriole GL, Bresalier R, Buys, S Chia, D Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes R, Johnson CC, Mandel JS, Oberman A, O’Brien B, Oken M, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials, 2000, 21(6S):273S-309S.

Ristvedt ST, McFarland EG, Weinstock LB, Thyssen EP. Patient preferences for CT colonography, conventional colonoscopy, and bowel preparation. The American Journal of Gastroenterology. 2003, 98(3), 578-585.

Schoen R., Weissfeld J et al. Patient satisfaction with screening flexible sigmoisoscopy, Archives of Internal Medicine, 2000, 160(12):1790-1796.

Schoen RE, Pinisky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA, July 2003, 290(1):41-48.

Schoen RE, Schragin J, Weissfeld JL, Thaete FL Evans RW, Rosen CJ, Kuller LH. Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. Cancer Epidemiology, Biomarkers and Prevention, June 2002, 11: 581-586.

Simpson NK, Johnson CC, Ogden S, Gamito E, Trocky N, McGuire C, Martin J, Barrow S, Lamerato L, Flickinger LM, Broski KG, Engelhard D, Hilke C, Bonk J, Gahagan B, Gren L, Childs J, Lappe K, Fouad M, Thompson J, Sullivan D. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Controlled Clinical Trials, 2000, 21(6S):356S-378S.

Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Controlled Clinical Trials, 2000, 21(6S):379S-389S.

Subar AF, Ziegler RG, Rhompson FE, Johnson CC, Weissfeld JL, Reding D, Kavounis KH, Hayes RB. Is shorter always better? relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. American Journal of Epidemiology. 2001, Vol. 153, No. 4.

Taylor KL, Shelby RA, Schwartz MD, Ackerman JL, Vholland, Gelmann EP, McGuire C. The impact of item order on ratings of cancer risk perception. Cancer Epidemiology, Biomarkers & Prevention, 2002; 11, 654-659.

Weissfeld J, Fagerstrom R, O’Brien B. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials, 2000, 21(6S):390S-399S.

Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok P. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Cancer, 2002;94:2569-76.

Wendelboe AM, Hegmann KT, Biggs JJ, Cox CC, Portmann AJ, Gildea JH, Gren LH, Lyon JL. Relationships between body mass indices and surgical replacements of knee and hip joints. American Journal of Preventive Medicine, 2003;25(4).

Whiting BR, McFarland EG, Brink JA. Influence of image acquisition parameters on CT artifacts and polyp depiction in spiral CT colonography: in vitro evaluation. Radiology, 2000:217(1):165-172.


Top of Page

Abstracts and Presentations

Andriole GL, Pinsky PF, Levin DL, Gelmann EP, Crawford ED, Reding D, Prorok PC, Gohagan JK, The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: biopsy rates and cancer characteristics of initial (T0) screen (II), Presented at AACR, New Orleans, LA, March 2001.

Bhalla S, McFarland EG, Feng F, McDermottt R, Ju A, Menias C, Hara AK, Huete A, Brink JA, Littenberg B, Pilgram TK. Prospective MDCT study of CT colonography compared to colonscopy: diagnostic performance of experienced and recently training readers. Presented at Society of Computed Body Tomography (SCBT), March 2002.

Bresalier RS, Pinsky P, Weissfeld J, Schoen R, Church T, Yokochi L, Prorok P, Effectiveness of nurse endoscopists in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Presented atDigestive Disease Week, San Francisco, CA, May, 2002 (published abstract)

Chang S, Leitzmann M, Peters U, Chatterjee N, Schatzkin A, Hayes RB, Association of dietary fat and colorectal adenoma, Presented at American Association of Cancer Research (AACR), Orlando, FL, March 2004

Chatterjee N, Wacholder S, Hayes RB, Exploiting multivariate disease classification in assessing etiology and treatment heterogeneity, Presented at American Associate of Cancer Research (AACR), Orlando, FL, March 2004

Chatterjee N, A two-stage regression approach to etiologic studies of heterogeneous disease, Presented at NIH Research Festival, Oct. 2003 (poster session)

Crawford ED, Chia D, Andriole GL, PSA changes as related to the initial PSA: data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, Presented at 37 th Annual American Society of Clinical Oncology, San Francisco, CA, May 2001.

Crawford ED, Chia D, Andriole GL, Reding D, Gelmann WP, Gohagan J, Pinsky P, Hayes R, Levin DL, Fagerstrom R, Kramer B. PSA changes as related to the initial PSA: data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, Presented at American Urological Association (AUA) Annual Meeting, Anaheim, CA, June 2001 (poster session)

Crawford ED, Chia D, Andriole GL, Reding D, Gelmann EP, Gohagan JK, Pinsky P, Hayes RB, Levin DL, Fagerstrom RM & Kramer BS. PSA changes as related to the initial PSA: data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial. Presented at American Society of Clinical Oncology Annual Meeting, Orlando, FL, May 2002.

Crawford ED, Chia D, Andriole GL, Reding D, Gelmann EP, Gohagan JK, Pinsky P, Hayes RB, Levin DL, Fagerstrom RM, Kramer BS, PSA Testing interval, reduction in screening intervals: data from the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial, Presented at American Urological Association, Orlando, FL, May 2002 (published abstract)

Crawford ED, Chia D, Andriole GL, Reding D, Gelmann EP, Gohagan JK, Pinsky P, Hayes RB, Levin DL, Fagerstrom RM, Kramer BS, PSA testing interval, reduction in screening intervals: data from the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial, Presented at 81 st Annual Meeting of the South Central Section of the American Urological Assoc., Inc. Colorado Springs, CO, Oct. 5-9, 2002.

Crawford ED, Chia D, Andriole GL, Reding D, Gelmann EP, Gohagan JK, Pinsky P, Hayes RB, Levin DL, Fagerstrom RM, Kramer BS. PSA testing interval, reduction in screening intervals: data from the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial, Presented at 81 st Annual Meeting of the American Urological Association, Colorado Springs, CO, October 2002.

Cross AJ, Peters U, Hayes RB, Andriole G, Reding D, Sinha R. Heterocyclic amines, PhIP, found in meat cooked at high temperatures may increase prostate cancer risk , Presented at American Association of Cancer Research (AACR) March 2004, Orlando, FL.

Cross AJ, Peters U, Hayes RB, Andriole G, Reding D, Sinha R. Heterocyclic amines, PhIP, found in meat cooked at high temperatures may increase prostate cancer risk , Presented at American Society of Preventive Oncology (ASPO), Bethesda, MD, March 2004.

Dixon LB, Peters U, Subar AF, Schatzkin A, Graubard B, Hayes RB. Multiple diet diversity scores and colorectal adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial, Presented at 36 th Annual Meeting of the Society for Epidemiologic Research Meeting, June, 2003, Atlanta, GA.

Dixon LB, Peters U, Subar A, Schatzkin A, Hayes R. Following the US food guide pyramid is associated with reduced risk of colorectal adenoma: findings from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, Experimental Biology Meeting, April 2004, Washington, DC.

Fagerstrom RM, Marcus PM, Prorok PC, Kramer BS, Greenwald P, Gohagan JK, Issues in the design, operations, and analysis of multi-disease screening trials: The Prostate,Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Experience. Presented at 3 rd Joint Meeting of the International Society of Clinical Biostatisticians and the Society for Clinical Trials, July 21, 2003.

Fagerstrom R, Buys S, Makhija S, Reding D, Riley T, Partridge, Jr. EE, Fouad M, Patterns of diagnostic follow-up for positive ovarian cancer screening tests, Presented at 34 th Annual Meeting of Society of Gynecologic Oncologists, New Orleans, LA, February 2003 (poster session)

Ford ME, Havstad SL, Flickinger L, Lamerato L, Johnson CC, Gohagan J. The effects of false positive lung cancer screening test results on subsequent lung cancer screening adherence, Presented at American Association for Cancer Research (AACR), March 2001.

Foster CB, Aswath K, Hayes R, Church T, Mayo C, Chanock SJ, Peters U. Using a fine haplotype map to study the role of glutathione peroxidase 1 (GPX1) in cancer susceptibility, Presented atSelenium Biochemistry 2003, Celebrating 30 Years of Selenoprotein Research, NHLBI, December 2003, Bethesda, MD.

Gohagan JK & Pinsky PF, Flexible Sigmoidosocopy screening in the PLCO Trial, Presented at Colorectal Cancer Screening Workshop for Persons of Average Risk, Bethesda, MD, March 1-2, 2001.

Gunter M, Hayes RB, Yeager M, Welch R, Schoen RE, Yokochi L, Chatterjee N, Schatzkin A, Peters U, Insulin resistance-related genes and colorectal adenoma risk, American Association of Cancer Research (AACR) Meeting, Orlando, FL, March 2004

Hartge P, Hayes R, Sherman RB, Prorok PC, Schiffman M, Reding D, Buys S, Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the PLCO Cancer Screening Trial, Presented at American College of Epidemiology Annual Meeting, Atlanta, GA. Sept. 25, 2000 (poster session)

Hayes RB, Smith CO, Kopp W, Whole Blood Cryopreservation in prospective epidemiologic studies of cancer, Presented at American Association for Cancer Research (AACR), March 2001

Hayes RB, Occupational and Environmental Epidemiology Branch Site Visit, May 2003. (Presentation)

Hayes RB, Etiologic and early marker studies in the PLCO trial, Presented at the NCI US-Japan Meeting on Cohorts in Epidemiologic Research, February 2004, San Diego, CA.

Hou L, Chatterjee N, Baccarelli A, Huang W, Caporaso N, Weissfeld J, Ji B, Gohagan J, Hayes RB. CYP1A1 (I462V) and NQO1 (P187S) polymorphisms, smoking, and colorectal adenoma: a report from the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. Presented at American Association of Cancer Research (AACR) – Frontiers in Cancer Prevention Research Meeting, Phoenix, AZ, October 2003. (Poster Session)

Hou L, Chatterjee N, Huang WY, Weissfeld J, Gohagan J, Hayes RB. CYP1A1 (I462V) and NQO1 (P187S) polymorphisms, smoking, and colorectal adenoma. Presented at the NIH Research Festival, 2003 (poster session)

Huang WY , Kang D, Weissfeld JL, Bresalier RS, Hayes RB. DNA repair polymorphisms and risk of colorectal adenoma in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Presented at Annual Meeting of the Society for Epidemiologic Research, Palm Desert, CA, June 2002 (Published Abstract American Journal of Epidemiology 2002; 155:14)

Huang WY, Dean M, Schoen R, Johnson C, Hayes RB, Microsomal epoxide hydrolase polymorphisms in association with cigarette use for risk of advanced colorectal adenoma in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Presented at American Association of Cancer Research (AACR), Waikoloa, HI, Jan, 2003; NIH Research Festival, 2003.

Huang WY, Berndt SI, Chatterjee N, Chanock SJ, Yeager M, Welch R, Weissfeld JL, Bresalier RS, Hayes RB, Nucleotide excision repair polymorphisms and risk of colorectal adenoma, American Association of Cancer Research (AACR), Orlando, FL, March 2004.

Ji BT, Weissfeld JL, Chow WH. Schoen R, Hayes RB, Relation of tobacco use to risk of colorectal adenomatous polyps and colorectal cancer in the U.S. PLCO Trial - a preliminary report. Presented at American Assoc. for Cancer Research (AACR), 91 st Annual Meeting, San Francisco, CA, April 2000.

Lamerato L , Johnson CC, Factors related to recruitment to a cancer screening trial, Presented at American Society of Preventive Oncology (ASPO). Philadelphia, PA, March 2003 (published abstract)

LaSalle VH, Mangan P, Shelby RA, Ackerman J, Gelmann EP, McGuire C, Taylor KL. Predictors of adherence in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Presented Eastern Psychological Association Annual Meeting, Washington, DC, April 20-22, 2001

Leitzmann MF, Chang C, Huang WY, Kirsh V, Peters U, Chatterjee N, Andriole G, Schatzkin A, Hayes, R. Interrelation of energy intake, body size, and physical activity with prostate cancer in the PLCO Screening Trial. Presented at NIH Research Festival, 2003 (poster session)

Levin D, Gelmann E, et al, Free and total PSA in 7,183 pilot study participants in the PLCO Screening Trial, Presented at American Urological Association Meeting (AUA) May 1999.

Mangan P, Shelby RA, Gelmann E, McGuire C, Taylor KL, Predictors of exam difficulty and adherence in the PLCO Cancer Screening Trial, Presented at Annual Meeting of the American Society of Preventive Oncology (ASPO) 2002.

Mayo CP, Huang WY, Hayes RB, Fouad MN, Obesity and colorectal adenoma: data from the Prostate, Lung Colorectal and Ovarian Cancer Screening Trial, Presented at American Institute for Cancer Research Annual Conference - Diet, Nutrition and Cancer. Washington, DC, July 11-12, 2002 (poster session)

Mayo CP, Huang WY, Hayes RB, Fouad MN, Obesity and colorectal adenoma: data from the Prostate, Lung Colorectal and Ovarian Cancer Screeing Trial – Supplement. International Research Conference on Food, Nutrition & Cancer. American Society of Nutritional Sciences, Journal of Nutrition, November 2002, 132:3540S-3556S (published abstract)

McDermott RA, McFarland EG, Brink JA, Ristved S, Menias CA, Littenberg B, Pilgram TK. Prospective comparison of air and CO2 insufflation techniques at CT colonography: evaluation of image quality and patient reactions. Presented at Radiological Society of North America (RSNA), December 2001, Radiology 2001;221(P):578. (Published abstract)

McFarland EG, Brink JA, Heiken JP, Balfe DM, Pilgram TK, Littenberg B. Polyp detection with spiral CT colongraphy: diagnostic performance using 2D and 3D displays. Presented at Radiological Society of North America (RSNA), December 1998 (Hot Topics).

McFarland EG, Brink JA, Heiken JP, Balfe DM, Hirselj DA, Pilgram TK, Argiro V, Littenberg B. Spiral CT Colonography (Virtual Colonoscopy): Multi-observer Study of Different Image Display Techniques Compared to Colonoscopy, Presented at International Society for Optical Engineering (SPIE), San Diego, CA, February 1999; SPIE Proceedings 1999;3660:106-108. (published abstract)

McFarland EG, Brink JA, Heiken JP, Balfe DM, Pilgram TK, Littenberg B. Reliability and accuracy of polyp size measurement with spiral CT colonography. Presented at Radiological Society of North America (RSNA), December 1999. RAD 213(P):258. (Published abstract)

McFarland EG, Brink JA, Heiken JP, Balfe DM, Santillan C, McDermott R, Pilgram T. Diagnostic performance and interobserver variability in prospective comparison of spiral CT colonography and colonoscopy, Presented atSociety of Computed Body Tomography (SCBT), April 2000.

McFarland E, McDermott RA, Brink JA, Heiken JP, Balfe DM, Santillan C, Pilgram TK, Evaluation of polyp size measurement in multi-observer prospective study of CT colonography, Presented at Society of Computed Body Tomography (SCBT), March 2001.

McFarland EG, Menias C, McDermott RM, Feng F, Brink JA, Littenberg B, Pilgram T. Prospective study of CT colongraphy (air vs CO2 insufflation techniques) and colonscopy: assessments of procedure times and image quality, Presented at Society of Gastrointestinal Radiology, Orlando, Florida, April 14, 2002.

McFarland E, Virtual colonoscopy, Plenary Session: Emerging Science and Technology, Presented at the American Society of Gastroenterology Postgraduate Course, Digestive Disease Week, San Diego, CA, May 21, 2003.

McFarland EG, Whiting BR, Cheung GY, Chung J, Parikh S, Pilgram TK, Brink JA. CT colonography of sessile polyps: in vitro evaluation of 4D and 16DCT protocols – comparison of radiation dose and slice thickness, Presented at Fourth International Symposium of Virtual Colonoscopy, Boston, MA, October 14-15, 2003.

McGlynn KA, Sakoda L, Hu Y, Hayes RB, Schoen RE, Bresaliler RS, Chanock S, Yadavilla,S, Buetow KH, Polymorphisms in iron-related loci and risk of adenomatous polyps in the PLCO Cancer Screening Trial, 6 th International Conference on SNP and Complex Genome Analysis, Nov. 2003, Chantilly, VA.

Moore L, Huang WY, Chanock S, Yaeger M, Pinsky P, Weissfeld J, Hayes RB. Risk of advanced adenoma associated with GSTM1, GSTT1, and two GSTP1 genotypes and cigarette smoking the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Presented at American Association of Cancer Research (AACR), Orlando, FL, March 2004.

Peters U, Sinha R, Chatterjee N, Subar A, Ziegler R, Brresalier R, Weissfeld JL, Flood A, Hoover RN, Schatzkin A, Hayes RB, and the PLCO Study Group. New life for the dietary fiber and colorectal neoplasia hypothesis? Results from the Prostate, Lung, Colorectal and Ovarian (PLCO) Trial, Presented at Society for Epidemiologic Research Annual Meeting, Toronto, June 13-16, 2001.

Peters U, Chatterjee N, Hayes RB, Robert Schoen, Church T, Bresalier RS, Gaudet, M, Flood A, Schatzkin A, McGlynn KA, and the PLCO Project Team, Association of calcium intake and colorectal adenoma, Presented at 35 th annual meeting of the Society for Epidemiologic Research, Palm Desert, CA, June 18 - 21, 2002.

Peters U, Hayes R, Chatterjee N, Church TR, Mayo C, Chanock S & Foster C, Polymorphisms in the selenoprotein glutathione peroxidase 1 and risk of colorectal adenoma, Presented at American Association of Cancer Research (AACR) International Conference, Molecular and Genetic Epidemiology of Cancer, January 18-23, 2003; NIH Research Festival, October 2003 (poster session)

Peters U, Hayes RB, Chatterjee N, Church TR, Mayo C, Sturup S, Chanock SJ, Foster CB, Serum selenium and genetic variation in the selenoprotein GPX1 and risk of colorectal adenoma, Presented at Association of Cancer Research (AACR), Orlando, FL, March 2004.

Peters U, Chatterjee N, Yeager M, Chanock S, Schoen RE, McGlynn KA, Church TR, Weisfeld J, Schatzkin A, Hayes, RB, Polymorphisms in the calcium sensing receptor, calcium intake and risk fo colorectal adenoma, Presented at 6 th International Conference on SNP, Chantilly, VA, November 2003.

Peters U, Sinha R, Chatterjee N, Subar A, Ziegler R, Bresalier R, Weissfeld JL, Flood A, Hoover RN, Schatzkin A, Hayes RB & PLCO Team, Dietary fiber and prevalence of colorectal adenoma, NIH Fellows Award for Research Excellence Fare 2002.

Reding D. Biomolecular studies in collaboration with the PLCO Screening Trial. Presented at the EDRN Meeting, February 2004.

Ristvedt S, McFarland EG, Weinstock L, Thyssen E, Patient appraisals of CT colonography, conventional colonoscopy, and the bowel preparation. Presented at Third International Symposium of Virtual Colonscopy, April 8-10, 2002, Boston, MA.

Sakoda LC, Hayes RB, Huang WY, Peters U, Chatterjee N, Andriole GL, Church TR, Chia D, Hoover RN, Hsing AW, Use of aspirin and ibuprofen in relation to prostate cancer risk in a prospective study, P resented at American Association of Cancer Research (AACR), Orlando, FL, March 2004.

Shelby R, Taylor K, LaSalle H, Ackerman J, Gelmann E, McGuire C, Baseline quality of life (QOL) characteristics among Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial participants at Georgetown University, American Society of Preventive Oncology (ASPO), 24 th Annual Meeting, March 5-7, 2000.

Shelby RA, Taylor KL, Schwartz MD, Ackerman J, LaSalle VH, Gelmann EP, McGuire C, The effect of question order in the assessment of perceived risk. Society of Behavioral Medicine, March 2001.

Smith AW, Rogers C, Riechman SE, Schoen RE, Weissfeld JL, Kriska A, Lifetime physical activity and adenoma risk among older adults in Pittsburgh, P resented at Society of Behavioral Medicine, Baltimore, MD, March 25, 2004 (poster presentation)

Stolzenberg-Solomon RZ, Leitzman M, Chang SS, Lacey J, Johnson K, Johnson C, Buys S, Hoover R, Zeigler R. Dietary folate intake, alcohol and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Society of Epidemiology Research (SER) Annual Meeting, June 15-18, 2004, Salt Lake City, UT (published abstract)

Taylor KL, Quality of life in the PLCO Cancer Screening Tria l. The NCI’s Workshop on Health Related Quality of Life and Cost Effectiveness Studies, Annapolis, MD, Nov. 1998.

Taylor K, Conducting behavioral ancillary studies in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, NCI Tobacco Branch Meeting in February 2003.

Taylor, KL, Africano NL, Cox LS, Tercyak KP, Waters AJ, Shields PG, Gelmann EP & Neff SE, Tobacco use among lung cancer screening participants, American Society of Preventive Oncology. Philadelphia, PA, March 2003.

Taylor KL, Shelby RA, LaSalle H, Ackerman J, Gelmann E, McGuire C. The impact of abnormal cancer screening results on quality of life. Annals of Behavioral Medicine, 23, S070, 2001 (published abstract)

Tenorio S, Ogden SL, Crawford ED, Gamito EJ. Latino recruitment into the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Presented at Cancer, Culture and Literacy Conference at the Moffitt Cancer Center, May 2002.

Tenorio S, Ogden SL, Crawford ED, Gamito EJ. Hispanic recruitment into the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Tenorio S, Ogden , S, Crawford ED, Gamito E, Methods and lessons learned in recruiting latinos for a large randomized cancer screening trial. 130 th Annual Meeting of American Public Health Association www.apha.org web site. November 2002.

Tenorio S, Ogden S, Crawford, ED, Gamito E, Methods and Lessons Learned in Recruiting Latinos for a Large Randomized Cancer Screening Trial, 130 th Annual Meeting of American Public Health Association, November 2002.

Tenorio S, Ogden SL, Crawford ED, Gamito EJ, Latino recruitment into the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, Presented at the Cancer, Culture and Literacy Conference at the Moffit Cancer Center, Clearwater Beach, FL May 2002. Presented to the 7 th National Conference on Nursing Research Meeting, San Diego, CA, February 2003.

Trauth J, Jernigan J, Neal-Ferguson D, Siminoff L, Weissfeld J, Understanding african american women’s decision to join a cancer screening clinical trial, Presented at 128 th American Public Health Association Annual Meeting, Boston, MA, Nov.15, 2000.

Trauth J, Jernigan J, Neal-Ferguson D, Siminoff L, Weissfeld J. Recruitment decisions of african american women regarding participation in the PLCO Cancer Screening Trial. Presented at the 128 th American Public Health Association Meeting, Boston, MA, Nov. 15, 2000.

Weissfeld & Schoen, Lack of association between screen detection of colorectal adenoma and family history of colorectal cancer, Presented at Digestive Diseases Week (DDW), May 1999.

Weissfeld JL, Ling BS, Schoen RE, Bresalier R, Riley T, Repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, Digestive Disease Week Meeting, San Diego, CA, May 2000.

Wendelboe AM, Hegmann KT, Gren LH, Alder SC, White GL, Lyon JL, Association between body mass indices and surgeries for rotator cuff tendinitis, 36 th Annual Meeting of the Society for Epidemiologic Research, June 2003, Atlanta, GA.

Wendelboe AM, Hegmann KT, Biggs JJ, Cox CC, Portmann AJ, Gildea JH, Gren LH, Lyon JL, Relationships between body mass indices and surgical replacements of the knee and hip joints. Presented at the 35 th annual meeting of the Society for Epidemiologic Research, Palm Desert, CA, June 18-21, 2002.

Whiting BR, McFarland EG, Dellabarca C, Brunsden BB. CT artifacts in virtual colonoscopy. Presented at International Society for Optical Engineering (SPIE), San Diego, CA, February 1999, SPIE Proceedings 1999; 3660:110-116 (published abstract)

Whiting BR, McFarland EG, Brunsden B, Dellabarca C, Wang G, Brink JA. Spiral CT colography rippling artifact: influence of acquisition parameters on 3D virtual endoscopy images using in vitro colon phantom, Presented at Radiological Society of North American (RSNA); RAD 1998;209 (P):429 (published abstract)

Whiting BR, McFarland EG, Brink JA, Parker JS, Hui D, Fox SH. Multidetector vs single detector CT colonography: invitro investigation of lesion conspicuousness and rippling artifact, Presented at Radio logical Society of North America (RSNA); RAD 1999; 213(P):197 (published abstract)


Top of Page


Sections

Updates

Facts about PLCO Cancers

Screening Centers

Participant Newsletters

Dietary Questionnaires

Resource Links

PLCO Intranet for Staff Only

Home Page

HOME | DICTIONARY | SITE MAP | SEARCH
ACCESSIBILITY | PRIVACY POLICY | CONTACT DCP

National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov